AEON Biopharma, Inc. - Class A Common Stock, par value $0.0001 per share (AEON)

29 filings reported holding AEON - AEON Biopharma, Inc. - Class A Common Stock, par value $0.0001 per share as of Q2 2024.
AEON Biopharma, Inc. - Class A Common Stock, par value $0.0001 per share (AEON) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.42M shares of 11.3M outstanding shares and own 83.29% of the company stock.
Largest 10 shareholders include Atalaya Capital Management LP (3.68M shares), Polar Asset Management Partners Inc. (3.68M shares), VANGUARD GROUP INC (751K shares), BlackRock Inc. (272K shares), Ikarian Capital, LLC (258K shares), GEODE CAPITAL MANAGEMENT, LLC (187K shares), Formidable Asset Management, LLC (114K shares), Davidson Kempner Capital Management LP (90.1K shares), STATE STREET CORP (61K shares), and BOOTHBAY FUND MANAGEMENT, LLC (55.1K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.